Ultragenyx Pharmaceutical Inc (NAS:RARE)
$ 41.87 -0.74 (-1.74%) Market Cap: 3.48 Bil Enterprise Value: 3.11 Bil PE Ratio: 0 PB Ratio: 24.80 GF Score: 70/100

Ultragenyx Pharmaceutical Inc at Jefferies London Healthcare Conference Transcript

Nov 17, 2022 / 10:25AM GMT
Release Date Price: $35.12 (-0.28%)
Farzin Haque
Jefferies LLC, Research Division - Equity Associate

Hi, everyone. My name is Farzin Haque. I'm an associate from Morris team at Jefferies. It's a pleasure to welcome Emil Kakkis, CEO of Ultragenyx. I think he has a few slides to start off with.

Emil D. Kakkis
Ultragenyx Pharmaceutical Inc. - Founder, President, CEO & Director

Yes.

Farzin Haque
Jefferies LLC, Research Division - Equity Associate

Welcome.

Emil D. Kakkis
Ultragenyx Pharmaceutical Inc. - Founder, President, CEO & Director

Thank you for having me. It's good to be in London. It's been so long since I've been in London. Walking around Covent Garden, been a while, it's been in a long time, too long. Happy to be here in London again, one of my favorite places and talk to you a little about where Ultragenyx is.

12 years ago with me and my secretary, couple of million dollars, and this is where we are today. With the commercial franchise, there is a forward-looking statement,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot